Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Clinical trial NCT03048877 · UNKNOWN

Trial details

NCT number: NCT03048877
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Differentiated Thyroid Cancer

Start date: 2016-12-01
Primary completion: 2020-03-25
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.